Michael Katz
9Patents
4h-index
11Co-inventors
50Inventor score
Filing activity: Feb 21, 2006 → Apr 20, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8895287B2 | Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US8343739B2 | Metabolically engineered cells for the production of pinosylvin | Chemistry; Metallurgy | 6 | Active |
| US8518677B2 | Microbial bioreaction process | Chemistry; Metallurgy | 5 | Active |
| US8569024B2 | Production of stilbenoids | Chemistry; Metallurgy | 5 | Active |
| US9040269B2 | Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US9822374B2 | Production of metabolites | Chemistry; Metallurgy | 2 | Active |
| US9404129B2 | Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9725743B2 | Metabolically engineered cells for the production of pinosylvin | Chemistry; Metallurgy | 0 | Active |
| US9834793B2 | Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.